All Studies

Discovery of anti-SARS-CoV-2 secondary metabolites from the heartwood of Pterocarpus santalinus using multi-informative molecular networking.

A study found that a pigment-depleted extract from the heartwood of L. f. contains compounds with potential anti-SARS-CoV-2 activity. This discovery emphasizes the significance of advanced analytical methods in identifying treatments and understanding natural compounds' therapeutic abilities.

Wasilewicz A et al (2023).
Front Mol Biosci.
PubMed:
37347040

Promising roles of Zingiber officinale roscoe, Curcuma longa L., and Momordica charantia L. as immunity modulators against COVID-19: A bibliometric analysis.

Study examines therapeutic potential of antioxidant, anti-inflammatory, immune-stimulating plants against SARS-CoV-2. India leads research, proposes herbal blend for COVID-19 treatment and prevention.

Sheikh HI et al (2023).
J Agric Food Res.
PubMed:
37346755

Diospyros lotus leaf extract and its main component myricitrin regulate pruritus through the inhibition of astrocyte activation.

The study focuses on the potential use of the plant extract and its main component, myricetin, in alleviating histamine-independent pruritus (itching). By evaluating the effects on signal transducer and activator of transcription 3 (STAT3) activation, glial fibrillary acidic protein (GFAP) expression, and lipocalin-2 (LCN2) production in astrocytes, as well as scratching behavior, mast cell infiltration, and IL-6 levels in mice, the researchers found that the extract and myricetin inhibited STAT3 activation, GFAP expression, and LCN2 release in astrocytes. Moreover, they also ameliorated scratching behavior and other allergic responses in mice. These findings suggest that the plant extract and myricetin could be potential therapeutic agents for the treatment of pruritus.

Shin JY et al (2023).
Exp Ther Med.
PubMed:
37346401